RNA-Seq – News and Features

Rubicon Genomics will develop the TransPlex™ WTA technology which can be used for amplifying total RNA from a variety of sample sources.

All three institutions will rely on Agilent’s genomics solution, comprising microarrays, reagents, hardware and data analysis tools.

Collaboration to create facility for proteomics profiling of RNAi and drug effects in human cells.

Molecules targeted at various cancers, inflammatory diseases and cardio-vascular indications.

All three institutions will rely on Agilent’s genomics solution, comprising microarrays, reagents, hardware and data analysis tools.

DYN G.S. is aiming to become a specialized center for providing sequencing services.

Research and Markets announces the addition of "The Future of Metabolomics: Building Competitive Advantage in Drug Discovery, Clinical Development and Diagnostics"

Max Planck will use Roche’s Genome Sequencer 20 system to produce a draft genome sequence for the Bonobo or Pygmy Chimpanzee.

The agreement gives Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.

Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.